Form 8-K - Current report:
SEC Accession No. 0000950170-22-018508
Filing Date
2022-09-15
Accepted
2022-09-14 18:08:05
Documents
12
Period of Report
2022-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20220909.htm   iXBRL 8-K 57657
  Complete submission text file 0000950170-22-018508.txt   174898

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20220909.xsd EX-101.SCH 2472
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20220909_pre.xml EX-101.PRE 9842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20220909_lab.xml EX-101.LAB 13350
6 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20220909_htm.xml XML 4726
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 221243951
SIC: 2834 Pharmaceutical Preparations